Upstream Bio, Inc. UPB Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upstream Bio, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upstream Bio, Inc.'s total liabilities & equity?
- Upstream Bio, Inc. (UPB) reported total liabilities & equity of $318.05M in Q1 2026.
- How has Upstream Bio, Inc.'s total liabilities & equity changed year-over-year?
- Upstream Bio, Inc.'s total liabilities & equity decreased by 30.3% year-over-year, from $456.17M to $318.05M.
- What is the long-term trend for Upstream Bio, Inc.'s total liabilities & equity?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s total liabilities & equity has grown at a 73.7% compound annual growth rate (CAGR), from $117.2M to $353.77M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.